| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer | See Remarks
1 company
Townsend Adam J. is a Chief Commercial Officer at Apellis Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 3 sells.
Estimated insider holdings value: $3.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 8, 2022 | APLS Apellis Pharmaceuticals, Inc. | Chief Commercial Officer | Sale+OE | 12,500 | $65.00 | $812,500.00 | -22.6% | -23.6% | -61.3% | |
| Aug 3, 2022 | APLS Apellis Pharmaceuticals, Inc. | Chief Commercial Officer | Sale+OE | 5,000 | $56.43 | $282,150.00 | -11.7% | +4.8% | -58.8% | |
| Jul 11, 2022 | APLS Apellis Pharmaceuticals, Inc. | Chief Commercial Officer | Sale+OE | 5,000 | $48.42 | $242,100.00 | -10.4% | +24.1% | +85.3% |